IRMD
IRADIMED CORPORATION Healthcare - Medical Devices Investor Relations →
IRADIMED CORPORATION (IRMD) closed at $99.50 as of 2026-03-20, trading 98.9% above its 200-week moving average of $50.03. The stock is currently moving closer to the line, down from 100.7% last week. The 14-week RSI sits at 57, indicating neutral momentum.
Trading volume is running at 1.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.06 ratio) is neutral — neither side is clearly dominating.
Over the past 561 weeks of data, IRMD has crossed below its 200-week moving average 9 times. On average, these episodes lasted 10 weeks. Historically, investors who bought IRMD at the start of these episodes saw an average one-year return of +11.0%.
With a market cap of $1272 million, IRMD is a small-cap stock. The company generates a free cash flow yield of 0.5%. Return on equity stands at 24.8%, indicating strong profitability. The stock trades at 13.4x book value.
Over the past 10.8 years, a hypothetical investment of $100 in IRMD would have grown to $494, compared to $379 for the S&P 500. That represents an annualized return of 15.9% vs 13.1% for the index — confirming IRMD as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: IRMD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After IRMD Crosses Below the Line?
Across 9 historical episodes, buying IRMD when it crossed below its 200-week moving average produced an average return of +8.6% after 12 months (median +0.0%), compared to +19.8% for the S&P 500 over the same periods. 44% of those episodes were profitable after one year. After 24 months, the average return was +61.9% vs +46.6% for the index.
Each line shows $100 invested at the moment IRMD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
IRMD has crossed below its 200-week MA 9 times with an average 1-year return of +11.0% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2016 | Feb 2016 | 2 | 17.1% | -39.3% | +647.5% |
| Apr 2016 | May 2016 | 6 | 17.7% | -43.4% | +652.1% |
| Aug 2016 | Aug 2016 | 1 | 2.6% | -43.2% | +528.6% |
| Aug 2016 | Dec 2017 | 68 | 50.4% | -39.6% | +530.0% |
| Jan 2018 | Apr 2018 | 12 | 13.5% | +73.2% | +631.9% |
| Jul 2019 | Jul 2019 | 1 | 0.5% | +31.0% | +503.9% |
| Mar 2020 | Mar 2020 | 1 | 11.8% | +45.8% | +578.2% |
| Oct 2022 | Oct 2022 | 1 | 0.6% | +44.3% | +284.7% |
| Dec 2022 | Dec 2022 | 1 | 0.4% | +70.6% | +281.8% |
| Average | 10 | — | +11.0% | — |
Frequently Asked Questions
Is IRMD below its 200-week moving average?
No. IRADIMED CORPORATION (IRMD) is currently 98.9% above its 200-week moving average of $50.03. It would need to fall to $50.03 to cross below the line.
What is IRMD's 200-week moving average price?
IRADIMED CORPORATION's 200-week moving average is $50.03 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when IRMD drops below its 200-week moving average?
IRMD has crossed below its 200-week moving average 9 times in our data. On average, buying at that moment produced a one-year return of +11.0%. These dips have historically been decent entry points. These episodes lasted 10 weeks on average.
Is IRMD a good value right now?
Here's what our data says about IRMD as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 57. Free cash flow yield is 0.5%. Return on equity is 24.8%. Price-to-book is 13.4x. This is not a buy or sell recommendation — always do your own research.
How does IRMD compare to the S&P 500?
Over the past 10.8 years, $100 invested in IRMD would have grown to $494, compared to $379 for the S&P 500. That's 15.9% annualized vs 13.1% for the index. IRMD has outperformed the broader market over this period.
Does IRMD pay a dividend?
Yes. IRADIMED CORPORATION currently pays a dividend yield of 81.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20